The major goal of this proposal is to elucidate the molecular basis by which compounds such as arsenic alter differentiation processes in human keratinocytes, a major target cell type. The conceptual framework for this work includes the hypotheses that (1) protein kinase C activity is important for keratinocyte differentiation, (2) this kinase ordinarily activates one or more DNA binding proteins responsible for differentiation- specific transcription, (3) chronic TPA treatment of sensitive target cells depletes them of the kinase and (4) arsenate (but not arsenite) prevents phosphorylation reaction(s) necessary for transcription factor activation. First, the molecular basis for arsenate suppression of a differentiation marker (involucrin) in cultured human keratinocytes will be explored. To determine whether transcription of the gene for this marker protein is suppressed, effects on mRNA stability and transcription factor action will be investigated. Second, effects of arsenate on protein kinase C will be examined. Measurements will include total activity, isozyme distribution and intracellular localization, possible alteration of differentiation specific substrates, and comparative action on keratinocytes at various stages of neoplasia. Third, to determine the importance of arsenic oxidation state in target epithelia, the rate of arsenate/arsenite interconversion will be compared in cells which do or do not show a sensitivity to arsenate suppression of differentiated function. Finally, extension of the above target cell analysis to combustion products will be explored. The actions of metal aerosols, as well as specific metal oxides and carbon-containing compounds, on epithelial cell differentiation and protein kinase C will be measured. In addition, the degree to which these combustion products, particularly those derived from chlorinated organics such as trichloroethylene, prevent keratinocyte growth will be measured. Whether this occurs by undergoing biotransformation to reactive metabolites or by stimulating the metabolism of other agents to which the keratinocytes are thereby sensitized will be determined. The results are anticipated to provide a basis for rational assessment of the carcinogenic risk posed to humans from exposure to arsenic and combustion products.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications